Galapagos reported EUR12.56M in Interest Income for its fiscal quarter ending in March of 2025.


Interest Income Change Date
argenx SE 38.4M 1.28M Jun/2025
AstraZeneca 68M 16M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
Genmab DKK 25M 8M Jun/2025
Gilead Sciences 73M 21M Jun/2025
GlaxoSmithKline 50M 4M Jun/2025
GRIFOLS 9.56M 4.5M Jun/2025
Hikma Pharmaceutical 4M 0 Dec/2024
Incyte 25.14M 2.21M Jun/2025
Merck 17M 11M Jun/2025
Roche Holding 2M 12M Dec/2020
Sanofi 76M 10M Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025